Safety and efficacy of preanesthetic H2 antagonist therapy for patients on oral rehydration therapy until 2 h before surgery

Safety and efficacy of preanesthetic H2 antagonist therapy for patients on oral rehydration therapy until 2 h before surgery - Safety and efficacy of preanesthetic H2 antagonist therapy for patients on oral rehydration therapy until 2 h before surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007499

Enrollment

Registered

2012-03-14

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

condition required surgery

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for elective surgery under general anesthesia

Exclusion criteria

Exclusion criteria: We excluted patients with gastrointestienal obstruction, body mass index (BMI) of 35 kg/m2 or larger, renal dysfunction (a creatinine clearance of 20ml/min or lower or dialysis ), pregnancy, the inability to take food orally, receiving gastroesophageal surgery previously, and long-term H2 antagonist medication.

Design outcomes

Primary

Measure	Time frame
gastric volume and its pH after anesthesia induction	—

Countries

Japan

Contacts

Public ContactMasatou Kitayama

Hirosaki University school of Medicine & Hospital Department of Anesthesiology

Outcome results